# A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

> **NCT02149602** · — · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 120 (actual)

## Conditions studied

- Oropharyngeal Squamous Cell Cancer
- Hypopharyngeal Squamous Cell Cancer

## Interventions

- **RADIATION:** Intensity modulated radiotherapy

## Key facts

- **NCT ID:** NCT02149602
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2011-11
- **Final completion:** 2014-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149602, "A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02149602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*